A Case of Paraneoplastic Immune Complex-Mediated Membranoproliferative Glomerulonephritis Due to High-Grade Prostate Small-Cell Neuroendocrine Carcinoma (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO0712; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "He is being treated with carboplatin and etoposide. RAS inhibition, rituximab and steroids have been tried. Complement inhibition is actively being studied but is not approved for treatment yet."
Clinical • Chronic Kidney Disease • Colorectal Cancer • Diabetes • Diabetic Nephropathy • Endocrine Cancer • Genito-urinary Cancer • Genitourinary Neuroendocrine Carcinoma • Glomerulonephritis • Hematological Malignancies • Immunology • Infectious Disease • Lupus Nephritis • Metabolic Disorders • Monoclonal Gammopathy • Nephrology • Neuroendocrine Carcinoma • Neuroendocrine Tumor • Oncology • Prostate Cancer • Renal Disease • Solid Tumor • Type 2 Diabetes Mellitus
|
|
Akshaya Ramaswami; Teresa Joseph; Randy L. Luciano
|